Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Resource and Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
LRP1 in vascular mural cells modulates cerebrovascular integrity and function in the presence of APOE4
Hiroshi Oue, … , Guojun Bu, Takahisa Kanekiyo
Hiroshi Oue, … , Guojun Bu, Takahisa Kanekiyo
Published April 10, 2023
Citation Information: JCI Insight. 2023;8(7):e163822. https://doi.org/10.1172/jci.insight.163822.
View: Text | PDF
Research Article Neuroscience

LRP1 in vascular mural cells modulates cerebrovascular integrity and function in the presence of APOE4

  • Text
  • PDF
Abstract

Cerebrovasculature is critical in maintaining brain homeostasis; its dysregulation often leads to vascular cognitive impairment and dementia (VCID) during aging. VCID is the second most prevalent cause of dementia in the elderly, after Alzheimer’s disease (AD), with frequent cooccurrence of VCID and AD. While multiple factors are involved in the pathogenesis of AD and VCID, APOE4 increases the risk for both diseases. A major apolipoprotein E (apoE) receptor, the low-density lipoprotein receptor-related protein 1 (LRP1), is abundantly expressed in vascular mural cells (pericytes and smooth muscle cells). Here, we investigated how deficiency of vascular mural cell LRP1 affects the cerebrovascular system and cognitive performance using vascular mural cell–specific Lrp1-KO mice (smLrp1–/–) in a human APOE3 or APOE4 background. We found that spatial memory was impaired in the 13- to 16-month-old APOE4 smLrp1–/– mice but not in the APOE3 smLrp1–/– mice, compared with their respective littermate control mice. These disruptions in the APOE4 smLrp1–/– mice were accompanied with excess paravascular glial activation and reduced cerebrovascular collagen IV. In addition, blood-brain barrier (BBB) integrity was disrupted in the APOE4 smLrp1–/– mice. Together, our results suggest that vascular mural cell LRP1 modulates cerebrovasculature integrity and function in an APOE genotype–dependent manner.

Authors

Hiroshi Oue, Yu Yamazaki, Wenhui Qiao, Chen Yuanxin, Yingxue Ren, Aishe Kurti, Francis Shue, Tammee M. Parsons, Ralph B. Perkerson, Keiji Kawatani, Ni Wang, Skylar C. Starling, Bhaskar Roy, Ioana-Emilia Mosneag, Tomonori Aikawa, Marie-Louise Holm, Chia-Chen Liu, Yasuteru Inoue, Patrick M. Sullivan, Yan W. Asmann, Betty Y.S. Kim, Guojun Bu, Takahisa Kanekiyo

×

Figure 4

LRP1 deletion in vascular mural cells decreases collagen-IV along brain capillaries in the mice with APOE4.

Options: View larger image (or click on image) Download as PowerPoint
LRP1 deletion in vascular mural cells decreases collagen-IV along brain ...
(A and B) Collagen IV was stained in frozen brain sections from 13- to 16-month-old male APOE3 control, APOE3 smLrp1–/–, APOE4 control, and APOE4 smLrp1–/– mice. Scale bars: 100 μm. Total fluorescence intensity of collagen IV in the cortical sections was quantified by ImageJ software (19–20 regions from 4 mice/group) and shown as a ratio to that of APOE3 control. (C–E) The levels of collagen IV (C), MMP2 (D), and MMP9 (D) in the cortex from 13- to 16-month-old male APOE3 control, APOE3 smLrp1–/–, APOE4 control, and APOE4 smLrp1–/– mice (n = 6–8/group) were determined by ELISA. Data are shown as mean ± SEM. *P < 0.05, ****P < 0.0001 by Student’s t test between control and smLrp1–/– mice in each APOE genotype.

Copyright © 2023 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts